![]() ![]() "Abrysvo is the first RSV vaccine indicated for passive immunization of infants from birth through six months of age following administration of the vaccine to the mother during pregnancy," the EMA said. It followed the EU-wide approval of GlaxoSmithKline's anti-RSV drug called Arexvy last month, which like Pfizer's shot could also be used for people over 60.īritish-Swedish pharmaceutical firm AstraZeneca and France's Sanofi's say their drug nirsevimab, marketed as Beyfortus, was the first treatment to prevent severe illness from RSV in infants-and was approved in the EU in November last year. ![]() The medicine, called Abrysvo and made by Pfizer, was approved in the United States in May. ![]() In severe cases it can cause pneumonia and bronchiolitis, an inflammation of the small airways deep inside the lungs. It is a leading cause of pediatric hospitalization in Europe, the EMA said. RSV normally causes mild, cold-like symptoms, but can be serious for infants, the elderly, those with weak immune systems and underlying conditions. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |